A Search Service for Abbreviation / Long Form

â–  Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 80
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : pts
Long Form : Patients
No. Year Title Co-occurring Abbreviation
2020 A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study). LMS, PFS
2019 A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer. ADC, AEs, MMAE, MTD
2019 Clinicopathological and molecular features of responders to nivolumab for patients with advanced gastric cancer. AGC, EBV, MMR, MMR-D, MMR-P, ORR, TC, TMB
2019 ELEVATE TN: Phase 3 Study of Acalabrutinib Combined with Obinutuzumab (O) or Alone Vs O Plus Chlorambucil (Clb) in Patients (Pts) with Treatment-Naive Chronic Lymphocytic Leukemia (CLL). CLB, CLL
2019 Initial Report of Second-Line FOLFIRI in Combination with Ramucirumab in Advanced Gastroesophageal Adenocarcinomas: A Multi-Institutional Retrospective Analysis. GEA, OS, PAC, PFS, ram, RAM
2019 Long-term outcome of patients with advanced pancreatic cancer treated with sequential chemotherapies before the era of modern combination therapy protocols. mPDAC
2019 Mining of Self-Organizing Map Gene-Expression Portraits Reveals Prognostic Stratification of HPV-Positive Head and Neck Squamous Cell Carcinoma. HNSCC, HPV, SOM
2019 Predicting the course of disease in recurrent vulvar cancer - A subset analysis of the AGO-CaRE-1 study. HRs
2019 Prospective multicentre study using high intensity focused ultrasound (HIFU) for the focal treatment of prostate cancer: Safety outcomes and complications. AE, HIFU
10  2019 Role of Interferon (IFN)alpha in "Cocktails" for the Generation of (Leukemia-derived) Dendritic Cells (DCleu) From Blasts in Blood From Patients (pts) With Acute Myeloid Leukemia (AML) and the Induction of Antileukemic Reactions. AML, GM-CSF, IFN, IFN-GIT, MNC, TNF, WB
11  2019 The addition of cetuximab to preoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma is associated with high rate of long term survival: Mature results from a prospective phase Ib/II trial. 5-FU, CRT, LAEC, MTD, pCR
12  2019 The use of a high-resolution mapping system may facilitate standard clinical practice in VE and VT ablation. BC, CA, FU, LV, VE, VT
13  2019 Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET)-The GREPONET Study. CI, HR, NET, NETs, PFS, ST, TGR, TGR3m, WW
14  2018 Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic. alts, LB, LB, mCRC, TB
15  2017 A phase I study of tivantinib in combination with temsirolimus in patients with advanced solid tumors. AEs, DLT, Gr, MTD, PK
16  2017 Bedside screening with the use of pocket-size imaging device can be useful for ruling out carotid artery stenosis in patients scheduled for cardiac surgery. CAS, DUS, PSID
17  2017 Evaluating lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours. LAN, WDDP
18  2017 Phase I study of axitinib and everolimus in metastatic solid tumours and extension to metastatic renal cell carcinoma: Results of EVAX study. AEs, AX, DLs, DLT, EV, Gr, mRCC, MTD, OD, PRs
19  2017 Safety and Efficacy of Abiraterone Acetate in Patients (pts) aged 75 or more with Metastatic Castration Resistant Prostate Cancer (mCRPC) in Both Pre-chemotherapy and Post-chemotherapy Settings: The Real Life Experience of Our Institution. mCRPC
20  2016 A pharmacodynamically guided dose selection of PF-00337210 in a phase I study in patients with advanced solid tumors. DLT, RP2D, VEGFR
21  2016 A phase I trial of the trifunctional anti Her2 anti CD3 antibody ertumaxomab in patients with advanced solid tumors. AE, DLT, ertu, MTD, SAE
22  2016 Clinicopathologic and survival analysis of resected ampullary adenocarcinoma. AAC, MVA, OS
23  2016 First Multicenter, Randomized Phase 3 Study in Patients (Pts) With Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL): Alisertib (MLN8237) Versus Investigator's Choice (LUMIERE trial; NCT01482962). PTCL, R/R
24  2016 First Multicenter, Randomized Phase 3 Study in Patients (Pts) With Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL): Alisertib (MLN8237) Versus Investigator’s Choice (LUMIERE trial; NCT01482962). PTCL, R/R
25  2016 May ultrasound probe size influence pain perception of needle piercing during transrectal prostate biopsy? A prospective evaluation. DRE, PP, VAS
26  2016 Randomized Phase 2 Open-Label Study of R-CHOP Bortezomib in Patients (Pts) With Untreated Non-Germinal Center B-Cell-like (Non-GCB) Subtype Diffuse Large Cell Lymphoma (DLBCL): Results From the Pyramid Trial (NCT00931918). Non-GCB
27  2016 Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group. CT, FU, HR, STS, UPS
28  2016 Treosulfan based reduced toxicity conditioning followed by allogeneic stem cell transplantation in patients with myelofibrosis. ---
29  2015 A phase I study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): an NRG Oncology/Gynecologic Oncology Group study. DL, DLT, i.p, MTD
30  2015 A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features. Ang-2, BEV, CAP, CRT, LARC
31  2015 Assessing novel prognostic serum biomarkers in advanced pancreatic cancer: the role of CYFRA 21-1, serum amyloid A, haptoglobin, and 25-OH vitamin D3. LLN, ln, MV, OS, PC, SAA, ULN
32  2015 Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie. CAP, CI, EGFR, GCs, HER2, LAP, ORR
33  2014 A phase I pharmacokinetics study of lapatinib and tamoxifen in metastatic breast cancer (EORTC 10053 Lapatam study). MBC, PK
34  2014 A pilot phase II Study of digoxin in patients with recurrent prostate cancer as evident by a rising PSA. ECGs, PCa, PSADT, VEGF
35  2014 Cardiac transplantation after bridged therapy with continuous flow left ventricular assist devices. CF-LVAD
36  2014 Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer. CRT
37  2014 Prognostic factors and efficacy of different chemotherapeutic regimens in patients with mediastinal nonseminomatous germ cell tumors. MNGCT, OS
38  2013 Enzymatic activity of DPIV and renin-angiotensin system (RAS) proteases in patients with left ventricular dysfunction and primary prevention implantable cardioverter/defibrillator (ICD). ACE2, APB, APN, DPIV, HR, ICD, IRAP, RAS, SCD
39  2013 Identification of distinct phenotypes of locally advanced pancreatic adenocarcinoma. HR, LAPC, LP, MP, OS, PFS, TTD
40  2012 Preload dependence of gated cardiac SPECT-derived ventricular volumes in hemodialysis patients. ESRD, HD, LV, LVEF, MPGS, TID
41  2012 Size of the transrectal ultrasound probe makes no difference in pain perception during TRUS-Bx under adequate local anesthesia. DRE, tPSA, VAS
42  2011 Effectiveness and Safety of PRECISE APC for the treatment of bleeding gastrointestinal angiodysplasia--a retrospective evaluation. ---
43  2011 Intensive care unit course of infants and children after cranial vault reconstruction for craniosynostosis. CSS, DOS, mo, WT
44  2011 Prevalence of spontaneous bacterial peritonitis in asymptomatic inpatients with decompensated liver cirrhosis - a pilot study. SBP
45  2010 Amongst eligible patients, age and comorbidity do not predict for dose-limiting toxicity from phase I chemotherapy. DLT, MTD
46  2010 Salvage treatment with upfront melphalan 100 mg/m(2) and consolidation with novel drugs for fulminant progression of multiple myeloma. ASCT, FPG, MEL100, MM, ORR
47  2009 Combination of amlodipine and enalapril in hypertensive patients with coronary disease. BP, CAD, DAP, LVEF, SAH, SAP
48  2009 First-line simplified GEMOX (S-GemOx) versus classical GEMOX in metastatic pancreatic cancer (MPA): results of a GERCOR randomized phase II study. MPA, S-GemOx, S-GemOx
49  2008 Cost-effectiveness of a new combined immunosuppressive and anti-infectious regimen in kidney transplantation. CMV
50  2007 Evaluation of gene panel mRNAs in urine samples of kidney transplant recipients as a non-invasive tool of graft function. AR, CAN, KT, KTP, SKF, Ur
51  2007 The value of adenosine test in the diagnosis of sick sinus syndrome: susceptibility of sinus and atrioventricular node to adenosine in patients with sick sinus syndrome and unexplained syncope. ADSNRT, AVN, CSNRT, SSS
52  2006 Short- and long-term experience in pulmonary vein segmental ostial ablation for paroxysmal atrial fibrillation. CRR, PAF, PV, PVI
53  2006 [Target organ damage in children with newly diagnosed and untreated essential hypertension]. ABPM, BMI, EH, fIMT, HR, LVH, PP, SBP
54  2005 Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II study. AEOC, GEM, PLD
55  2005 Protected circumferential conduction in the posterior atrioventricular vestibule of the left atrium: electrophysiologic and anatomic correlates. CS, LA, PAVV, RF
56  2005 Randomized trial of cytoreduction followed by intraperitoneal chemotherapy versus cytoreduction alone in patients with peritoneal sarcomatosis. IPEC, PS, VS
57  2005 [Long-term fate of left atrial thrombi and incidence of cerebral embolism under continuous anticoagulation therapy]. AF, DWI, INR, LA, MRI, TEE
58  2004 Timing isn't everything: an analysis of when to start salvage chemotherapy in ovarian cancer. CR, CT, PFS
59  2002 Phase 1 trial of the novel bispecific molecule H22xKi-4 in patients with refractory Hodgkin lymphoma. BSM, CR, HL, MoAb, MTD, PK, PR
60  2001 Early and medium term results of tailored therapy for heart failure. CI, Cr, dd, PWP, RAP, SAP, SVR
61  2001 Improved outcomes from a comprehensive management system for heart failure. CHF, CMP, NYHA
62  2001 Non-small cell lung cancer with single brain metastasis: the role of surgical treatment. NSCLC
63  1999 Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C. 5-FUDR, HAI, med. surv, MFFM, SC
64  1999 [High-dosage chemotherapy in primary metastasized and relapsed Ewing's sarcoma. (EI)CESS]. EFS, ET, HDT
65  1999 [High-dose ifosfamide in patients with stage IV non-small cell lung cancer: phase II trial from the Groupe francais de pneumo-cancerologie (GFPC)]. GFPC
66  1999 [Results of a prospective randomized trial with induction chemotherapy for cancer of the oral cavity and tonsils]. CR
67  1998 Mechanical circulatory support after orthotopic heart transplantation. IABP, RHF
68  1997 Extraction and replacement of permanent pacemaker leads through occluded vessels: use of extraction sheaths as conduits--balloon venoplasty as an adjunct. PPLs, SVC
69  1997 Free PSA in the detection of prostatic carcinoma. BPH, PCa
70  1996 A phase I trial of recombinant human interleukin-11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy. rhIL-11
71  1994 [NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphomas in children and adolescents. Part 2: An intermediate term analysis of the non-B-NHL therapy group. BFM Study group]. 6-MP, CP, i.th, L-ASP, MTX, VCR
72  1993 Comparison of 5 vs 10 micrograms/kg per day of GM-CSF following dose-intensified chemotherapy with cisplatin, etoposide, and ifosfamide in patients with advanced testicular cancer. GM-CSF
73  1993 Does adding conjoint therapy to individually focused alcoholism treatment lead to better family functioning? SOs
74  1993 [Photodynamic therapy (PDT) in roentgenographically occult lung cancer by photofrin II and excimer dye laser]. CA, CR, PDT
75  1992 [Diagnostic significance of absent nocturnal blood pressure decrease in 24-hour long-term blood pressure measurement]. BP
76  1992 [Doppler echocardiography in the diagnosis of mechanic complications of acute myocardial infarction]. AMI, ECOCG/DP, LVF
77  1991 [Ebstein's anomaly. Clinical aspects and surgical therapy]. VSD
78  1991 [Renal involvement in rheumatic (systemic) diseases: new diagnostic possibilities]. RA
79  1990 [High-dose leucovorin and 5-fluorouracil in advanced gastric and colorectal cancer. High-Dose Leucovorin and 5-FU Study Group]. dl-LV
80  1989 [Autologous blood transfusion in elective heart surgery: prospective study of 189 consecutive patients]. ---